Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of Regeneron Pharmaceuticals, Inc. (REGN)

Go back to Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of Regeneron Pharmaceuticals, Inc. (REGN)
Regeneron (NASDAQ: REGN) Delayed: 618.03 +5.53 (0.90%)
Previous Close $612.50    52 Week High $592.36 
Open $607.92    52 Week Low $325.35 
Day High $621.79    P/E 162.21 
Day Low $607.92    EPS $3.81 
Volume 1,279,853